Assembly Biosciences: Q2 Earnings Snapshot
Assembly Biosciences: Q1 Earnings Snapshot
Assembly Biosciences: Q3 Earnings Snapshot
Assembly Biosciences: Q2 Earnings Snapshot
Assembly Biosciences: Q1 Earnings Snapshot
Carver Biosciences, Inc., a biotech company focused on the development of CRISPR/Cas13 antivirals, today announced the formation of its Scientific Advisory Board (SAB). Cameron Myhrvold Ph.D., co-founder...
Assembly Biosciences: Q3 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company...
- Discontinues clinical development of vebicorvir, Assembly Bio’s first-generation core inhibitor, based on interim efficacy data from ongoing combination...
SOUTH SAN FRANCISCO, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company...